Monday, August 24, 2026
22.7 C
Bengaluru

Pharma CEO Roundtable on 27th October 2021

Engaging Doctors – Physical, Digital & Hybrid: Translating Strategy Into Action

Keynote Address: Rajaram Narayanan, Managing Director, Sanofi India

Pharma professionals can sign up here to receive the link to view the Pharma CEO Roundtable 2021.

Panel Members:

Digital will NOT make the pharma sales job redundant. Anything else you’ve heard to the contrary – is a MYTH. In fact, digital technology, digital platforms, and digital tools are an enabler for any Pharma salesperson to execute with sharper impact and reduce wastage.

How will this happen? Join us on the 27th of October as we bring together veterans of the industry and discuss what it truly means to go digital, understand the customer journey, identify the gaps, and leverage content via the right channels.

Highlights of the Pharma CEO Roundtable 2021

  • Mapping the customer journey
  • Identifying and filling the need-gaps of doctors
  • Content curation: What is engaging and why does it matter?
  • The omnichannel approach
  • The Sanofi experience

So, cast your inhibitions and fears away – and jump on the digital bandwagon. Pharma professionals can sign up here to receive the link to view the Pharma CEO Roundtable 2021.

Hot this week

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.

With over 25 years of leadership experience across commercial...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Topics

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...

Will President Trump’s Diktat Improve Drug Quality For Indian Patients?

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

Mounjaro is the Exceptional Growth Story: Ranks #1

The July Brand Monitor by Pharmarack shows a healthy...

Sun Pharma: In the Eye of the Storm of Ophthalmologists

The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...

Does India Need to Reinvent the Wheel on Junk Foods?

In a written reply in the Lok Sabha in...
spot_img

Related Articles

spot_imgspot_img